We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
+10.07%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$419M
AUM Growth
+$148M
(+54%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
30.92%
Top 10 Holdings %
Top 10 Hldgs %
12.65%
Holding
735
New
336
Increased
76
Reduced
46
Closed
277
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$6.95M |
| 2 |
Apple
AAPL
|
+$6.94M |
| 3 |
COL
Rockwell Collins
COL
|
+$5.18M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$5.04M |
| 5 |
Molson Coors Class B
TAP
|
+$4.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$9.64M |
| 2 |
Acuity Brands
AYI
|
+$4.57M |
| 3 |
Mondelez International
MDLZ
|
+$3.38M |
| 4 |
Costco
COST
|
+$2.98M |
| 5 |
Intuit
INTU
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.55% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Healthcare | 13.84% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Staples | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
151
DELISTED
CATALENT, INC.
CTLT
| $878K | 0.21% |
22,000
-12,527
| -36% | -$464K |
|
152
Genpact
G
$5.45B
| $871K | 0.21% |
+30,282
| New | +$862K |
|
153
TC Energy
TRP
$71.2B
| $870K | 0.21% |
+17,600
| New | +$884K |
|
154
Abercrombie & Fitch
ANF
$4.41B
| $869K | 0.21% |
60,200
+44,100
| +274% | +$504K |
|
155
Franco-Nevada
FNV
$41.4B
| $868K | 0.21% |
+11,200
| New | +$860K |
|
156
Twilio
TWLO
$29.5B
| $863K | 0.21% |
+28,900
| New | +$866K |
|
|
ARRS
157
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $860K | 0.21% |
30,200
+6,400
| +27% | +$177K |
|
|
EVHC
158
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $859K | 0.21% |
19,100
+13,800
| +260% | +$736K |
|
159
United Natural Foods
UNFI
$2.97B
| $857K | 0.2% |
+20,600
| New | +$767K |
|
160
Open Text
OTEX
$5.73B
| $845K | 0.2% |
+26,160
| New | +$847K |
|
161
TransDigm Group
TDG
$71.9B
| $844K | 0.2% |
+3,300
| New | +$893K |
|
162
Credit Acceptance
CACC
$5.78B
| $842K | 0.2% |
+3,004
| New | +$789K |
|
163
Etsy
ETSY
$7.96B
| $838K | 0.2% |
+49,673
| New | +$784K |
|
164
Graco
GGG
$13B
| $828K | 0.2% |
20,079
+10,566
| +111% | +$402K |
|
165
Sarepta Therapeutics
SRPT
$1.68B
| $826K | 0.2% |
18,200
+12,100
| +198% | +$484K |
|
166
Welltower
WELL
$175B
| $823K | 0.2% |
+11,713
| New | +$852K |
|
|
B
167
Barrick Mining
B
$62.6B
| $821K | 0.2% |
+51,000
| New | +$853K |
|
|
IRBT
168
DELISTED
iRobot
IRBT
| $817K | 0.2% |
10,600
+3,900
| +58% | +$357K |
|
169
RenaissanceRe
RNR
$13.7B
| $797K | 0.19% |
+5,900
| New | +$830K |
|
170
Zebra Technologies
ZBRA
$12.6B
| $790K | 0.19% |
+7,277
| New | +$747K |
|
171
Encompass Health
EHC
$11.3B
| $788K | 0.19% |
21,369
+2,263
| +12% | +$80.6K |
|
172
Teradata
TDC
$2.8B
| $787K | 0.19% |
+23,303
| New | +$724K |
|
173
LendingTree
TREE
$564M
| $784K | 0.19% |
3,206
+1,184
| +59% | +$256K |
|
174
NETSCOUT
NTCT
$2.86B
| $780K | 0.19% |
+24,100
| New | +$804K |
|
175
MasTec
MTZ
$26.6B
| $776K | 0.19% |
16,723
+7,600
| +83% | +$331K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Bayesian Capital Management held 735 positions worth $419M, up 54% from $271M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bayesian Capital Management deployed $129M of net new capital in Q3 2017, opening 336 new positions and adding to 76 existing holdings. Its largest new stake was Accenture: 53,319 shares worth $7.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Vodafone, an estimated $1.72M trimmed.
- Bayesian Capital Management's largest Q3 2017 buy was Accenture: 53,319 shares worth $7.2M.
- Bayesian Capital Management added most to Rockwell Collins in Q3 2017, an estimated $5.18M increase.
- Bayesian Capital Management's biggest Q3 2017 reduction was Vodafone, cutting an estimated $1.72M.
- Bayesian Capital Management fully exited Nike in Q3 2017, selling an estimated $9.64M.
- Bayesian Capital Management's ten largest holdings make up 13% of its $419M portfolio in Q3 2017.
- Bayesian Capital Management opened 336 new positions and closed 277 in Q3 2017.
- Bayesian Capital Management's portfolio value rose 54% quarter-over-quarter to $419M.
Based on Bayesian Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.